chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had the shots, just got over shingles/ Suspected vaccination failure; Just got over shingles; Painful; Sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and pain in arm. On an unknown date, the outcome of the vaccination failure, pain and pain in arm were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and pain in arm to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided are as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received both Shingles shots 2 years ago and just got over a case of the shingles. The patient had zero side effects from the vaccine other than a sore arm. The patient stated that according to his/her doctor it was a light case but it was painful nonetheless. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
pt recv vax & cried inconsolably for over 4hr;pt had recovered @ the date of this report;
sore throat; sensitive tongue; burning tongue; sinus inflammation; chills; fever; red blotchy; itching; whole arm hurt; fatigue; body aches/soreness; headache; nausea; not sleeping good; uncomfortable; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st January 2020, the patient received the 1st dose of Shingrix. On 1st January 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, fatigue and general body pain. On 2nd January 2020, the patient experienced injection site erythema and injection site itching. On 3rd January 2020, the patient experienced sinusitis, chills and fever. On 4th January 2020, the patient experienced sore throat, sensitive tongue and burning tongue. In January 2020, the patient experienced headache, nausea, poor sleep and discomfort. The patient was treated with ibuprofen (Advil) and paracetamol (Tylenol). On an unknown date, the outcome of the pain in arm, fatigue, general body pain, injection site erythema, injection site itching, headache, sensitive tongue, burning tongue, sinusitis, chills, fever, nausea, poor sleep and discomfort were unknown and the outcome of the sore throat was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, fatigue, general body pain, injection site erythema, injection site itching, headache, sore throat, sensitive tongue, burning tongue, sinusitis, chills, fever, nausea, poor sleep and discomfort to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and had whole arm hurt, she was fatigued and had body aches. The next day of reporting she had splotchy redness and itching at the site. She had a headache that started on the left side and moved to the right side and it has not gone away with help of Advil or Tylenol. She had a sore throat that started on the left side and moved to the right side and still sore. She notes her tongue was sensitive and burning, but worse when she eats. She has inflamed sinus, chills, and a fever of 101 that finally broke. She has nausea, she was not sleeping good because she was uncomfortable. She was referred to her physician.
Pt experienced fever. Approximately 7 days later the pt developed varicella with less than 10 lesions.
This spontaneous report as received from a medical assistant refers to an unspecified patients of unknown demographics. On an unknown dates, the patients were administered with improperly stored VARIVAX (strength unspecified) lot # L024253 with exp. date: 01-JUL-2017; lot # L024256 with exp. date: 01-JUL-2017; lot# L001328 with exp. date: 13-JAN-2017 and lot # L016123 with exp. date 06-MAY-2017. No adverse effects were reported. The vaccine was exposed to temperature of 10.47F for a time frame of 62 hours and 30 minutes. No previous temperature excursion involved. No data logger involved. No product quality complaint involved. No additional information was provided. Additional information has been requested.
warm to the touch rump at the site of injection; Wales at the wrist; wales at the stomach; itchy rump at the injection site; itchy rump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch rump at the site of injection), URTICARIA (Wales at the wrist), URTICARIA (wales at the stomach), VACCINATION SITE MASS (itchy rump at the injection site) and VACCINATION SITE PRURITUS (itchy rump at the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.    Co-suspect product included non-company product LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ) for an unknown indication.    The patient's past medical history included No adverse event.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ) (unknown route) at an unspecified dose. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch rump at the site of injection), URTICARIA (Wales at the wrist), URTICARIA (wales at the stomach), VACCINATION SITE MASS (itchy rump at the injection site) and VACCINATION SITE PRURITUS (itchy rump at the injection site). At the time of the report, VACCINATION SITE WARMTH (warm to the touch rump at the site of injection), URTICARIA (Wales at the wrist), URTICARIA (wales at the stomach), VACCINATION SITE MASS (itchy rump at the injection site) and VACCINATION SITE PRURITUS (itchy rump at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included benadryl
PAtient seen in ED and transferred for inpatient admission.  The patient is a 48-year-old gentleman was admitted to our service with concerns of hypoxia possibly related to COVID.  On presentation, the patient was noted to have persistent tachycardia and complaints of dizziness.  Given the patient's negative chest x-ray hypoxia and sinus tachycardia seemed out of proportion with his Infectious presentation.  CT of the chest was obtained given patient's history of significant PE.  CTA of the chest noted pulmonary embolism of significant size and portion including saddle pulmonary embolism with right heart strain.  A alert was sent out and the determination was made the patient will be best served to be transferred for ongoing workup and consideration of catheter directed therapy.Patient is a 48 y.o. male with h/o morbid obesity, essential HTN and PE s/p thrombectomy and IVC placement (Oct 2020)/removal (Feb 2021), transferring directly from Pennock Hospital where he was admitted on 1/2 with acute hypoxic respiratory failure initially thought secondary to COVID-19 pneumonia with later discovery of acute bilateral pulmonary embolism with saddle embolus.  He presented to the ER yesterday morning with c/o 1-week h/o dizziness in the setting of recent viral URI-type symptomatology.  These symptoms have included congestion, sinus drainage, sore throat, rhinorrhea, non-productive cough and dyspnea with exertion.  He was admitted here in Oct 2020 due to above noted prior PE and, following thrombectomy and IVC filter placement, he was discharged in stable condition on Coumadin for anticoagulation as his BMI limits other options.  It appears this anticoagulation was stopped in Jan 2021 in preparation for IVC filter retrieval in Feb 2021, and it was never restarted thereafter.  On arrival to the ER, he was found to be hypoxic and is now comfortable and maintaining appropriate SpO2 on 4L via NC.  He has been afebrile, normotensive, tachycardic and mildly tachypnic.  Initial labs suggest mild AKI with mild NAGMA, troponinemia with negative delta, elevated proBNP, elevated D-dimer, mild leukocytosis and positive COVID screen.  He was admitted to the hospitalist service at Pennock pre-CTA thorax and received COVID-directed dexamethasone and remdesivir.  Of note, aside from the large clot burden on CTA, the lungs appeared otherwise clear with no e/o pneumonia.  He was started on a heparin infusion and transfer was requested for possible repeat thrombectomy and Pulm consult here as noted by Dr.
Feelings of numbness to the right side of my body.   Feelings of Bells Palsy.
itching; Initial information received on 28-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-HCP  This case involves a 91 years old female patient who experienced itching after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 30-Sep-2022, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at a dose of 0.7 ml  total (lot number: not reported; strength, formulation and expiry date unknown) via intramuscular route in left deltoid  for Influenza Immunization.  On 02-OCT-2022 the patient developed  itching (pruritus) 2 days following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported Caller reported her mother received FLUZONE HIGH-DOSE QUADRIVALENT on 30SEP2022 and started itching on 2OCT2022 and has been ever since. She was taken to the Doctor on 4OCT2022 and has been prescribed Benadryl, Hydroxyzine, Prednisone and had an injection of Solumedrol that relieved symptoms for about 2 days. No hives, blisters, bumps observed.   Action taken  was not applicable.  The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Pruritus, HYDROXYZINE (HYDROXYZINE) for Pruritus, PREDNISONE (PREDNISONE) for Pruritus and METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) for Pruritus.  At time of reporting, the outcome was Not Recovered / Not Resolved for the event itching.
Patient tested positive for COVID-19 after completing the full Moderna vaccine series, 70 days after 2nd dose.  Patient received 2nd dose of COVID vaccine on 1/25/21.  Tested positive on 4/5/21.  NOT hospitalized.
Started having multiple seizure lasting 3-5 minutes and occuring 5-7 times a day. Temp up to 103/104. Before seizures start told by Dr was hiccups, came back in 2 wks and was referred to neurologist, 60 day follow up dated 6/29/00 states the child is developmentally delayed. Having trouble with emotions and temper.
104 fever & fussiness 9 days after MMR vaccine given (along with PENTACEL).  Patient's fever resolved by 48 hours and there were no other associated symptoms (ie rash or cold symptoms)
Mensural Cycle Changes.   I have been on the same birth control for about 10 years and have had a regular cycle.  After receiving the Pfizer vaccine I started my period on 12/8/2021 and am continuing to bleed as of 12/28/2021.  The first 15 days were very heavy with large blood clots (changing sanitary napkins about 8-10 times per day).  The bleeding has since slowed down and the clots have stopped but this cycle has definitely been abnormal for me.
pt recv vax;itching on the way home from ofc;devel body redness & itching/swelling;to er for exam;solumedrol & dph given;pt was observed & resolved;
approx 20 days p/vax pt was hosp w/>103 temp, vomiting, diarrhea, swollen lymph glands in neck & redness of face & neck;
Shingles; This case was reported by a nurse via sales rep and described the occurrence of shingles in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th August 2019, the patient received the 1st dose of Shingrix. On 6th September 2019, 8 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The nurse reported that, after vaccination with dose of Shingrix, the patient diagnosed with shingles. The reporter had concerned because it happened to another patient, which would report after completion of this report. This case has been linked with case US2019AMR167067, repored by same reporter.
CONGESTION IN LUNGS COUGHING UP THICK SECRETIONS EVER SINCE
vaccine administration was perfect.  About 1700 a severe pain started in the left mastiod bone. I tried Excedrin Migraine and massage, I applied cold and hot compresses to no avail, pain fluctuated, tried to sleep, pain became worse and more consistent; pain became less frequent Saturday and Sunday morning there was a noticiable difference in the sides of my face. Monday my eye wouldnt close properly and the left side of my mouth would not open so I went to the Urgent Care for treatment
Left arm sore, very swollen, and warm after shot. To relieve the pain, I took two ALEVE Pain Reliever and rubbed arm with alcohol. After two days, left arm developed a red ring around the upper arm at shot injection site. The area is very sore and it hurts when touched.
Welts; Welts are itchy; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional via Pfizer. A 64-year-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: ER8732) via an unspecified route of administration, administered in left arm on 01Apr2021 13:45 (at the age of 64-year-old) as single dose and first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6208) via an unspecified route of administration, administered in left arm on 11Mar2021 01:30 as single dose for COVID-19 immunization. Medical history included latex sensitivity and penicillin allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not received any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had been not tested for COVID-19 since the vaccination. On 12Mar2021 06:00, the next morning the patient had welts, appeared not near vaccine location. First appeared on lower arm, wrist, then on ankle, then on side of body, welts were itchy. Patient thought it might have been a bug bite the first time, but it has happened again after the second injection. No treatment received for the events. No unaddressed medical questions referred or forwarded to Medical Information. The outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
Patient got vaccine on 5/17 she came today 5/14 and told me she has sore and warmness in the area where the vaccine was given and she has little pain in the injection area. I told her that it is the side effects and ask her to put ice and use ibuprofen and also told her to check with her primary physician.
Loss of appetite and not being able to drink. I get sick after I eat and was in the ER due to dehydration. I also had to go again due to my heart racing. My normal BP is 110/70 and it was 145/98 and my resting heartrate is 65-75 and it spiked to 149.
Adm vaccine on 12/06/2007 and client inform us of pregnancy 12/14/2007
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with a first dose of GARDASIL (lot #, expiration date, dose and route were not reported). Secondary suspects and concomitant therapies were not reported. The nurse practitioner stated that unspecified number of patients returned to the office on unspecified dates over 1 year later after receiving a first dose of GARDASIL to receive a second dose of GARDASIL. No adverse symptoms reported. Additional information has been requested.
got / shot 1 / about a year and a couple months ago / has not yet received dose 2; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose intramuscularly a year and couple months ago of the reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by patient himself. The age at vaccination was not applicable for this report.. Till the time of reporting, the patient not yet received dose 2 of Shingrix vaccine, which led to incomplete course of vaccination. The patient received dose 1 intramuscularly and did not have exact date and did not have the lot number or expiration date. The reporter did not consent to follow up. The patient did not want to share his MD contact information.
Spine has been stiff/stiffness in the spine; Could barley walk around; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Spine has been stiff/stiffness in the spine) and GAIT DISTURBANCE (Could barley walk around) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Degenerative disc disease.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Spine has been stiff/stiffness in the spine) and GAIT DISTURBANCE (Could barley walk around). At the time of the report, MUSCULOSKELETAL STIFFNESS (Spine has been stiff/stiffness in the spine) and GAIT DISTURBANCE (Could barley walk around) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Pt with GERD, showed apnea on monitor. (30 week preemie) Reglan and ranitidine discontinued by mom, 2 weeks ago. Found lifeless at home. EMT's in ambulance tried resuscitation and this was continued at the ER. No response.  COD: undetermined, manner of death: undetermined Per F/U 5/22/01: Lungs show petechiae bilaterally and also in thymus. Also states; child was found unresponsive in bed shared with mother and another individual. Hospital course complicated by necrotizing enterocolitis, anemia, mild hyperbilirubinemia, periodic breathing (treated with caffeine), edema and mild metabolic acidosis. Discharged after birth on caffeine, ranitidine and Reglan. The cause of death could not be determined.
This case was reported by a consumer via call center representative and described the occurrence of coldness of lower extremities in a 61-year-old male patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. On 19th July 2018, the patient received the 2nd dose of SHINGRIX .5 ml. In July 2018, less than a day after receiving SHINGRIX, the patient experienced coldness of lower extremities, leg discomfort, knee pain, pain in arm, injection site erythema and injection site pain. In July 2018, the outcome of the coldness of lower extremities, leg discomfort, knee pain, pain in arm and injection site erythema were recovered/resolved. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the coldness of lower extremities, leg discomfort, knee pain, pain in arm, injection site erythema and injection site pain to be related to SHINGRIX. Additional information was received as follows: The reporter mentioned that he experienced reactions within 24 hours after receiving the dose of SHINGRIX. The reporter stated that he woke up out of sleep and his lower extremities from the knees down to feet felt cold and had intermittent uncomfortable feelings. The reporter stated that he had pain in knees that he could feel when he climbed stairs and also had the pain at the injection site and redness as well, but added that the pain was not as bad as when he received the 1st dose of SHINGRIX. The coldness and uncomfortable feelings in his legs lasted through the night, and the pain in arm, pain in knees, and redness lasted for about 3 days. This case has been linked to the case US2018131388 (the patient's wife) and US2018086699 (same patient), reported by the same reporter.
Initial misuse report received from healthcare professional on 20 December 2013. The cases were received on 21 March 2014 at agency. FLUZONE ID was given to a patient over 64 years of age (No other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
N/A, patient presented for first dose of COVID vaccine but had actually received a dose of Moderna 10 days earlier from another facility. Not discovered until reconciliation in state database
Patient complains of weakness and cough productive of yellow sputum with mild shortness of breath, denies chest pain, fever, chills, loss of taste/smell, or diarrhea.
9 days after receiving my first injection of MODERNA vaccine my arm started itching around the site after turning red.  My vaccine my arm sore originally for a day or so and it it was 9 days later that the problem began.  By the 10th day I had a large oval shaped rash that is hot  to the touch (even through my clothes), it itches, it is a large oval and red with some bumps.  My question is can I get the second dose of this vaccine?